An examination of the use of CD19 CAR NK-92 cells to induce complete remission and vaccine effect against rechallenge in a highly aggressive murine leukemia.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: ImmunityBio (United States), Sanford Health, Tufts Medical Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890172293